These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6209731

  • 1. The effects of variable doses of 5-azacytidine on fetal hemoglobin production in sickle cell anemia.
    Dover GJ, Charache SH.
    Prog Clin Biol Res; 1984; 165():73-83. PubMed ID: 6209731
    [No Abstract] [Full Text] [Related]

  • 2. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ, Charache S, Boyer SH.
    Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
    [No Abstract] [Full Text] [Related]

  • 3. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
    Dover GJ, Charache S, Nora R, Boyer SH.
    Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
    [No Abstract] [Full Text] [Related]

  • 4. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1989; 316B():295-306. PubMed ID: 2482499
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA.
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract] [Full Text] [Related]

  • 6. [Fetal hemoglobin].
    Rokicka-Piotrowicz M.
    Postepy Hig Med Dosw; 1989; 43(5-6):475-97. PubMed ID: 2484927
    [Abstract] [Full Text] [Related]

  • 7. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG.
    Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
    [No Abstract] [Full Text] [Related]

  • 8. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
    Platt OS.
    Am J Pediatr Hematol Oncol; 1985; 7(3):258-60. PubMed ID: 2416231
    [Abstract] [Full Text] [Related]

  • 9. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
    Coleman E, Inusa B.
    Clin Pediatr (Phila); 2007 Jun; 46(5):386-91. PubMed ID: 17556734
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R, Veith R, Papayannopoulou T, Stamatoyannopoulos G.
    Prog Clin Biol Res; 1985 Jun; 191():433-45. PubMed ID: 2413479
    [No Abstract] [Full Text] [Related]

  • 11. The effect of increased fetal hemoglobin production on the frequency of vaso-occlusive crisis in sickle cell disease.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1987 Jun; 240():277-85. PubMed ID: 2441416
    [No Abstract] [Full Text] [Related]

  • 12. Levels of fetal hemoglobin necessary for treatment of sickle cell disease.
    Noguchi CT, Rodgers GP, Serjeant G, Schechter AN.
    N Engl J Med; 1988 Jan 14; 318(2):96-9. PubMed ID: 2447498
    [No Abstract] [Full Text] [Related]

  • 13. 5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.
    Humphries RK, Dover G, Young NS, Moore JG, Charache S, Ley T, Nienhuis AW.
    J Clin Invest; 1985 Feb 14; 75(2):547-57. PubMed ID: 2579100
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM, Pace B.
    Pediatr Pathol Mol Med; 2001 Feb 14; 20(1):87-106. PubMed ID: 12673846
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H, Sutton M, Atweh GF.
    Ann N Y Acad Sci; 2005 Feb 14; 1054():228-37. PubMed ID: 16339670
    [Abstract] [Full Text] [Related]

  • 16. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
    Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG.
    J Clin Invest; 1984 Aug 14; 74(2):652-6. PubMed ID: 6205021
    [Abstract] [Full Text] [Related]

  • 17. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH.
    Trends Pharmacol Sci; 2006 Apr 14; 27(4):204-10. PubMed ID: 16530854
    [Abstract] [Full Text] [Related]

  • 18. Erythropoietin stimulates F-reticulocyte formation in sickle cell anemia.
    al-Khatti A, Umemura T, Clow J, Abels RI, Vance J, Papayannopoulou T, Stamatoyannopoulos G.
    Trans Assoc Am Physicians; 1988 Apr 14; 101():54-61. PubMed ID: 2480020
    [No Abstract] [Full Text] [Related]

  • 19. 5-Azacytidine increases HbF production and reduces anemia in sickle cell disease: dose-response analysis of subcutaneous and oral dosage regimens.
    Dover GJ, Charache S, Boyer SH, Vogelsang G, Moyer M.
    Blood; 1985 Sep 14; 66(3):527-32. PubMed ID: 2411310
    [Abstract] [Full Text] [Related]

  • 20. 5-Azacytidine and fetal hemoglobin.
    Heller P, DeSimone J.
    Am J Hematol; 1984 Sep 14; 17(4):439-47. PubMed ID: 6208778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.